Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Akorn reports record consolidated revenue of $73.9 million in first quarter 2013

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for its first quarter ended March 31, 2013.

7 May 2013

New Process Analytical Technology for pharmaceutical and chemical manufacturing industries

Process Analytical Technology (PAT) is quickly becoming an integral component in the pharmaceutical and chemical manufacturing industries. Utilizing a low latency network of powerful chemometric instruments, multivariate data analysis software, process control tools, and a central SQL database, PAT provides pharmaceutical and biopharmaceutical companies an edge over their competitors.

From Thermo Fisher Scientific Inc. 7 May 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

7 May 2013

New device extracts human DNA more quickly and efficiently

Take a swab of saliva from your mouth and within minutes your DNA could be ready for analysis and genome sequencing with the help of a new device.

7 May 2013

Researchers evaluate lung-related health impacts associated with engineered nanomaterials

For the first time, researchers from institutions around the country have conducted an identical series of toxicology tests evaluating lung-related health impacts associated with widely used engineered nanomaterials (ENMs).

7 May 2013

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round.

6 May 2013

STD Med receives second Certificate of Good Practices for Manufacturing of Class III Medical Devices

STD Med, Inc. is pleased to announce that it has received a second Certificate of Good Practices for Manufacturing of Class III Medical Devices from ANVISA, the Brazilian National Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria –ANVISA).

5 May 2013

Experts suggest ways to reduce morbidity, mortality caused by tobacco use

The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.

5 May 2013

GOP sparring puts Medicaid expansion in limbo in several red states

News outlets report that several Republican governors who came out in favor of the expansion are battling with conservative lawmakers as legislative sessions wind down.

4 May 2013

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM (Modular Protein Technology) molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit, currently underway in Boston, MA.

3 May 2013

Cambrex sales increase by 5.7% in first quarter 2013

Cambrex Corporation reports results for the first quarter ended March 31, 2013.

3 May 2013

Tosoh Bioscience announces GPC glossary and column selection mobile app

Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.

2 May 2013

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.

30 Apr 2013

3D surgical microscopes from Leica Microsystems and TrueVision® debut at AANS Annual Meeting

Leica Microsystems and TrueVision® 3D Surgical announced the debut of 3D surgical microscopes at the 81st Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS).

29 Apr 2013

RainDance Technologies announces closing of $20M Series E financing round

RainDance Technologies, Inc., the Digital Biology Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. has joined as a new strategic equity investor.

29 Apr 2013

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.

From Thermo Fisher Scientific Inc. 26 Apr 2013

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Dyax Corp. today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide) business, the broader angioedema portfolio and the Licensing and Funded Research Program (LFRP).

26 Apr 2013

Rochester Medical's net sales increase 8% to $16,635,000 in second quarter 2013

Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.

26 Apr 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.

26 Apr 2013

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

IGI Laboratories, Inc., a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the first quarter ended March 31, 2013.

26 Apr 2013

Manufacturing News and Research

Further Reading

Akorn reports record consolidated revenue of $73.9 million in first quarter 2013

New Process Analytical Technology for pharmaceutical and chemical manufacturing industries

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

New device extracts human DNA more quickly and efficiently

Researchers evaluate lung-related health impacts associated with engineered nanomaterials

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

STD Med receives second Certificate of Good Practices for Manufacturing of Class III Medical Devices

Experts suggest ways to reduce morbidity, mortality caused by tobacco use

GOP sparring puts Medicaid expansion in limbo in several red states

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

Cambrex sales increase by 5.7% in first quarter 2013

Tosoh Bioscience announces GPC glossary and column selection mobile app

Viewpoints: Bowles, Simpson renew push for 'grand bargain;' The debate on FDA oversight of pharmacies; Kasich and feds work to find formula for Medicaid expansion

3D surgical microscopes from Leica Microsystems and TrueVision® debut at AANS Annual Meeting

RainDance Technologies announces closing of $20M Series E financing round

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Dyax reports Q1 2013 financial results; LFRP portfolio continues to be a growth driver

Rochester Medical's net sales increase 8% to $16,635,000 in second quarter 2013

Greatbatch reports 19% increase in adjusted diluted EPS targets for first quarter 2013

IGI Laboratories net revenues increase 101% to $3.7M in first quarter 2013

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News